The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 1925-1930

  Holte, Hege Ruge ^a   Bjørnstad Østensen, Anniken ^a   Berg, Torill ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Blood pressure; Bradykinin; Bradykinin antagonist; Captopril; Converting enzyme inhibitor; Hypertension; NO; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN; BRADYKININ; BRADYKININ ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; KININ; KININASE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENTOLAMINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; ENZYME INHIBITION; HOMEOSTASIS; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029811065     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15626.x     Document Type: Article

References (22)

1. BENETOS, A., GAVRAS, I. & GAVRAS, H. (1986a). Hypertensive effect of a bradykinin antagonist in normotensive rats. Hypertension, 8, 1089-1092.
2. BENETOS, A., GAVRAS, H., STEWART, J.M., VAVREK, R.J. HATINOGLOU, S. & GAVRAS, I. (1986b). Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. Hypertension, 8, 971-974.
3. BERG, T., JOHANSEN, L. & NUSTAD, K. (1985). Enzymatic activity of rat submandibular gland kallikrein released into blood. Am. J. Physiol., 249, H1134-H1142.
4. BJØRNSTAD-ØSTENSEN, A. & BERG, T. (1994). The role of nitric oxide, adrenergic activation and kinin-degradation in blood pressure homeostasis following an acute kinin-induced hypotension. Br. J. Pharmacol., 113, 1567-1573.
5. BURNSTOCK, G. (1990). Local mechanisms of blood flow control by perivascular nerves and endothelium. J. Hypertens., 8, Suppl. 7, S95-S106.
6. CACHOFEIRO, V., SAKAKIBARA, T. & NASJLETTI, A. (1992). Kinins, nitric oxide, and the hypotensive effect of captopril and Ramiprilat in hypertension. Hypertension, 19, 137-145.
7. CARBONELL, L.F., CARRETERO, O.A., STEWART, J.M. & SCICLI, A.G. (1988). Effect of a kinin antagonist on the acute antihypertensive activity of Enalaprilat in severe hypertension. Hypertension, 11, 239-243.
8. CARRETERO, O.A., MIYAZAKI, S. & SCICLI, A.G. (1981). Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril. Hypertension, 3, 18-22.
9. DZAU, V.J. (1989). Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J. Hypertens., 7, 933-936.
10. GAVRAS, H., BRUNNER, H.R., TURINI, O.A., KERSHAW, G.R., TIFFT, C.P. & CUTTELOD, S. (1978). Antihypertensive effect of the oral angiotensin converting enzyme inhibitor SQ14225 in man. N. Engl. J. Med., 298, 991-995.
11. INAGAMI, T., MURAKAMI, T., HIGUCHI, K. & NAKAJO, S. (1991). Roles of renal and vascular renin in spontaneous hypertension and switching mechanism upon nephrectomy. Am. J. Hypertens., 4, 15S-22S.
12. KELM, M. & SCHRADER, J. (1988). Nitric oxide release from the isolated guinea pig heart. Eur. J. Pharmacol., 155, 317-321.
13. KIOWSKI, W., LINDER, L., KLEINBLOESEM, C., VAN BRUMMEL, P. & BÜHLER, F.R. (1992). Blood pressure control by the reninangiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation, 85, 1-8.
14. MOMBULI, J.V. & VANHOUTTE, P.M. (1995). Endothelium-derived hyperpolarizing factor(s) and the potentiation of kinins by converting enzyme inhibitors. Am. J. Hyper tens., 8, 19S-27S.
15. ØRSTAVIK, T.B. & GAUTVIK, K.M. (1978). Regulation of salivary kallikrein secretion in the rat submandibular gland. Acta Physiol. Scand., 100, 33-44.
16. ØRSTAVIK, T.B., CARRETERO, O.A. & SCICLI, A.G. (1982). Kallikrein-kinin system in regulation of submandibular gland blood flow. Am. J. Physiol., 242, H1010-1014.
17. O'SHAUGHNESSY, K.M., NEWMAN, C.M. & WARREN, J.B. (1992). Inhibition in the rat of nitric oxide synthesis in vivo does not attenuate the hypotensive action of acetylcholine, ATP or bradykinin. Exp. Physiol., 77, 285-292.
18. REES, D.D., PALMER, R.M.J., SCHULZ, R., HODSON, H.F. & MONCADA, S. (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
19. SAED, G.M., CARRETERO, O.A., MACDONALD, R.J. & SCICLI, A.G. (1990). Kallikrein messenger RNA in rat arteries and veins. Circ. Res., 67, 510-516.
20. WHITTLE, B.J.R., LOPEZ-BELMONTE, J. & REES, D.D. (1989). Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol., 98, 646-652.
21. WIRTH, K., HOCK, F.J., ALBUS, U., LINZ, W. & ALPERMANN, H.G. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol., 102, 774-777.
22. YANG, H.Y.T., ERDÖS, E.G. & LEVIN, Y. (1970). A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochem. Biophys. Acta, 214, 374-376.